Total Funding
70
54
Total FundingDebt Financing raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
105400
Medicud develops a device for treating wounds with negative pressure dressing.
- Antonio D'angelo: CEO and Co-Founder
- Andrea Cazzulani: CTO and Co-Founder
About the Company
Antonio D’Angelo & Andrea Cazzulani found out that an advanced medication with proven results was striving to become the standard of care because of several issues such as high price and unhandiness of current devices. Incisional negative pressure was loosing to absorbent wound dressing even if clinical data showed dramatic superiority. Antonio
& Andrea joined forces and in 2020 founded Medicud, invented and developed a novel easy-to-use and discreet single use i-NPWT device that can cut down therapy cost and reduced ecological footprint. Medicud aims to become the global leader of sustainable medical technologies.
